| Serial Number | 87335695 |
| Word Mark | CASLIA |
| Filing Date | Tuesday, February 14, 2017 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, August 31, 2020 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 30, 2017 |
| Goods and Services | Pharmaceutical preparations used in connection with anti-aging, namely, for use in the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, and for facial aesthetic surgery, facial aesthetic reconstruction, and breast aesthetic treatment procedures; topical antibiotics, anti-inflammatory, anti-infective, anti-glaucoma agents and decongestant formulations; sterile antibiotic ointments; ocular contact lens wetting solutions, artificial tears and pharmaceutical preparations for the treatment of minor ocular inflammations and allergic conditions; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lightener lotions and creams; Oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing pharmaceutical preparations; Pharmaceutical preparations and medicines for the treatment and prevention of sexual dysfunction; Pharmaceutical preparations and medicines for the treatment of sensory organ disorders; Pharmaceutical preparations and medicines for the treatment of urogenital organ disorders; Pharmaceutical preparations and medicines for the treatment of circulatory system disorders; Pharmaceutical preparations and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics; Antifungal preparations; Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism; Pharmaceutical and cosmeceutical preparations for skin care, namely, medicated skin cleansers, toners, moisturizers, rejuvenators, rehydrating creams, and lotions for the face and body |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, February 21, 2017 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Allergan Sales, LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Madison, NJ 07940 |
| Party Name | Allergan Sales, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Irvine, CA 92612 |
| Event Date | Event Description |
| Monday, August 31, 2020 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, August 31, 2020 | ABANDONMENT - NO USE STATEMENT FILED |
| Friday, January 17, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, January 16, 2020 | EXTENSION 5 GRANTED |
| Tuesday, January 14, 2020 | EXTENSION 5 FILED |
| Thursday, January 16, 2020 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Tuesday, January 14, 2020 | TEAS EXTENSION RECEIVED |
| Tuesday, June 18, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, June 14, 2019 | EXTENSION 4 GRANTED |
| Friday, June 14, 2019 | EXTENSION 4 FILED |
| Friday, June 14, 2019 | TEAS EXTENSION RECEIVED |
| Saturday, January 12, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, January 10, 2019 | EXTENSION 3 GRANTED |
| Thursday, January 10, 2019 | EXTENSION 3 FILED |
| Thursday, January 10, 2019 | TEAS EXTENSION RECEIVED |
| Wednesday, July 18, 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, July 16, 2018 | EXTENSION 2 GRANTED |
| Monday, July 16, 2018 | EXTENSION 2 FILED |
| Monday, July 16, 2018 | TEAS EXTENSION RECEIVED |
| Tuesday, December 12, 2017 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, December 8, 2017 | EXTENSION 1 GRANTED |
| Friday, December 8, 2017 | EXTENSION 1 FILED |
| Friday, December 8, 2017 | TEAS EXTENSION RECEIVED |
| Tuesday, July 25, 2017 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, May 30, 2017 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 30, 2017 | PUBLISHED FOR OPPOSITION |
| Wednesday, May 10, 2017 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, April 26, 2017 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Monday, April 24, 2017 | ASSIGNED TO LIE |
| Wednesday, March 22, 2017 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, March 22, 2017 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, March 22, 2017 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, March 22, 2017 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, March 22, 2017 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, March 20, 2017 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED |
| Monday, March 20, 2017 | LETTER OF SUSPENSION E-MAILED |
| Monday, March 20, 2017 | SUSPENSION LETTER WRITTEN |
| Saturday, March 11, 2017 | ASSIGNED TO EXAMINER |
| Tuesday, February 21, 2017 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Friday, February 17, 2017 | NEW APPLICATION ENTERED IN TRAM |